The role of endogenous interleukin-12 in resistance to murine cytomegalovirus (MCMV) infection and a novel action for endogenous IL-12 p40

Journal of Interferon and Cytokine Research

Volumn 19, Issue 10, 1999, Pages 1145-1152

  Carr, Jacqueline A ^a   Rogerson, Jane A ^a   Mulqueen, Michael J ^a   Roberts, Noel A ^a   Nash, Anthony A ^b  

^a Welwyn Garden City ^*  (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; PROTEIN P40;

ANIMAL EXPERIMENT; ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; INFECTION CONTROL; INFECTION RESISTANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CYTOMEGALOVIRUS INFECTIONS; IMMUNITY, NATURAL; INTERLEUKIN-12; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED BALB C; PEPTIDE FRAGMENTS; SURVIVAL RATE; UP-REGULATION;

ANIMALIA; CYTOMEGALOVIRUS; MAIZE CHLOROTIC MOTTLE VIRUS; MOUSE CYTOMEGALOVIRUS 1; MURINAE;

EID: 0032738008     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999099313082     Document Type: Article

References (43)

1. KOBAYASHI, M., FITZ, L., RYAN, M., HEWICK, R.M., CLARK, S.C., CHAN, S., LOUDON, R., SHERMAN, F., PERUSSIA, B., and TRINCHIERI, G. (1989). Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170, 827-846
2. STERN, A., PODLASKI, F.J., HULMES, J.D., PAN, Y.-C.E., QUINN, P.M., WOLITZKY, A.C., FAMILLETTI, P.C., STREMLO, D.L., TRUITT, T., CHIZZONITE, R., and GATELY, M.K. (1990). Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 87, 6808-6812.
3. WOLF, S.F., TEMPLE, P.A., KOBAYASHI, M., YOUNG, D., DICIG, M., LOWE, L., DZIALO, R., FITZ, L., FERENZ, C., HEWICK, R.M., KELLEHER, K., and PERUSSIA, B. (1991). Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immuno. 146, 3074-3081.
4. WOLF, S.F., SIEBURTH, D., and SYPEK, J. (1994). Interleukin 12: a key modulator of immune function. Stem Cells 12, 154-168.
5. CHEHIMI, J., VALIANTE, N.M., D'ANDREA, A., ROSADO, Z., KOBAYASHI, M., PERUSSIA, B., WOLF, S.F., STAR, S.E., and TRINCHIERI, G. (1993). Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumour-derived and virus-infected cells. Eur. J. Immunol. 23, 1826-1830.
6. CHEHIMI, J., STAR, S.E., FRANK, I., RENGARAJU, M., JACKSON, S.J., LLANES, C., KOBAYASHI, M., PERUSSIA, B., YOUNG, D., NICKBARG, E., WOLF, S.F., and TRINCHIERI, G. (1992). Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J. Exp. Med. 175, 789-796.
7. h2 cells. Eur. J. Immunol. 23, 1762-1770.
8. CARR, J.A., ROGERSON, J.A., MULQUEEN, M.J., ROBERTS, N.A., and BOOTH, R.F.G. (1997). Interleukin-12 exhibits potent antiviral activity in experimental herpesvirus infections. J. Virol. 71, 7799-7803.
9. GAZZINELLI, R.T., GIESE, N.A., and MORSE, H.C. (1994). In vivo treatment with interleukin-12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS). J. Exp. Med. 180, 2199-2208.
10. OZMEN, L., AGUET, M., TRINCHIERI, G., and GAROTTA, G. (1995). The in vivo antiviral activity of interleukin 12 is mediated by γ Interferon. J. Virol. 69, 8147-8150.
11. MILICH, D.R., WOLF, S.F., HUGHES, J.L., and JONES, J.E. (1995). Interleukin 12 suppresses autoantibody production by reversing helper T-cell phenotype in hepatitis B e antigen transgenic mice. Proc. Natl. Acad. Sci. USA 92, 6847-6851.
12. CAVANAUGH, V.J., GUIDOTTI, L.G., and CHISARI, F.V. (1997). Interleukin-12 inhibits hepatitis B virus replication in transgenic mice. J. Virol. 71, 3236-3243.
13. BI, Z., QUANDT, P., KOMATSU, T., BARNA, M., and REISS, C.S. (1995). IL-12 promotes enhanced recovery from vesicular stomatitis virus infection of the central nervous system. J. Immunol. 155, 5684-5689.
14. MONTEIRO, J.M., HARVEY, C., and TRINCHIERI, G. (1998). Role of interleukin-12 in primary influenza virus infection. J. Virol. 72, 4825-4831.
15. CHEHIMI, J., STARR, S.E., FRANK, I., D'ANDREA, A., MA, X., MACGREGOR, R.R., SENNELIER, J., and TRINCHIERI, G. (1994). Impaired interleukin 12 production in human immunodeficiency virus infected patients. J. Exp. Med. 179, 1361-1366.
16. ROSSOL, S., MARINOS, G., CARUCCI, P., SINGER, M.V., WILLIAMS, R., and NAOUMOV, N.V. (1997). Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B. J. Clin Invest 99, 3025-3033.
17. TONE, Y., THOMPSON, S.A.J., BABIK, J.M., NOLAN, K.F., TONE, M., RAVEN, C., and WALDMANN, H. (1996). Structure and chromosomal location of the mouse interieukin-12 p35 and p40 subunit genes. Eur. J. Immunol. 26, 1222-1227.
18. TRINCHIERI, G. (1994). Interieukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84, 4008-4027.
19. YOSHIMOTO, T., NAGASE, H., ISHIDA, T., INOUE, J.I., and NARIUCHI, H. (1997). Induction of interleukin-12 p40 transcript by CD40 ligation via activation of nuclear factor-kappa-B. Eur. J. Immunol. 27, 3461-3470.
20. SCHOENHAUT, D.S., CHUA, A.O., WOLITZKY, A.C., QUINN, P.M., DWYER, C.M., McCOMAS, W., FAMILLETTI, P.C., GATELY, M.K., and GUBLER, U. (1992). Cloning and expression of murine IL-12. J. Immunol. 148, 3433-3440.
21. DEVERGNE, O., BIRKENBACH, M., and KIEFF, E. (1997). Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 from a novel heterodimeric hematopoietin. Proc. Natl. Acad. Sci. USA 94, 12041-12046.
22. D'ANDREA, A., RENGARAJU, M., VALIATE, N.M., CHEHIMI, J., KUBIN, M., ASTE, M., CHAN, S.H., KOBAYASHE, M., YOUNG, D., NICKBARG, E., CHIZZONITE, R., WOLF, S.F., and TRINCHIERI, G. (1992). Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med. 176, 1387-1398.
23. LING, P., GATELY, M.K., GUBLER, U., STERN, A.S., LIN, P., HOLLFELDER, K., SU, C., PAN, Y.-C.E., and HAKIMI, J. (1995). Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J. Immunol. 154, 116-127.
24. GILLESSEN, S., CARVAJAL, D., LING, P., PODLASKJ, F.J., STREMLO, D.L., FAMILLETTI, P.C., GUBLER, U., PRESKY, D.H., STERN, A.S., and GATELY, M.K. (1995). Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur. J. Immunol. 25, 200-206.
25. KATO, K., SHIMOZATO, O., HOSHI, K., WAKIMOTO, H., HAMADA, H., YAGITA, I., and OKUMURA, K. (1996). Local production of the p40 subunit of interleukin 12 suppresses T-helper 1-mediated immune responses and prevents allogeneic myoblast rejection. Proc. Natl. Acad. Sci. USA 93, 9085-9089.
26. TREMBLEAU, S., PENNA, G., GREFORI, S., GATELY, M.K., and ADORINI, L. (1997). Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes. Eur. J. Immunol. 27, 2330-2339.
27. YOSHIMOTO, T., WANG, C.R., YONETO, T., WAKI, S., SUNAGA, S., KOMAGATA, Y., MITSUYAMA, M., MIYAZAKI, J., and NARIUCHI, H. (1998). Reduced T helper 1 responses in IL-12 p40 transgenic mice. J. Immunol. 160, 588-594.
28. PICCOTTI, J.R., CHAN, S.Y., GOODMAN, R.E., MAGRAM, J., EICHWALD, E.J., and BISHOP, O.K. (1996). IL-12 antagonism induces Th2 responses, yet exacerbates cardio-allograft rejection: evidence against a dominant protective role for Th2 cytokines in alloimmunity. J. Immunol. 157, 1951-1957.
29. + IFN-γ producing cells. J. Immunol. 158, 643-648.
30. MATTNER, F., MAGRAM, J., FERRANTE, J., LAUNOIS, P., DI-PADOVA, K., BEHIN, R., GATELY, M.K., LOUIS, J.A., and ALBER G. (1996). Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur. J. Immunol. 26, 1553-1559.
31. MAGRAM, J., CONNAUGHTON, S.E., WARRIER, R.R., CARVAJAL, D.M., WU, C., FERRANTE, J., STEWART, C., SARMIENTO, U., FAHERTY, D.A., and GATELY, M.K. (1996). IL-12 deficient mice are defective in IFN-γ production and type 1 cytokine responses. Immunity 4, 471-481.
32. COOPER, A.M., MAGRAM, J., FERRANTE, S., and ORME, I.M. (1997). Interleukin 12 is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 186, 39-45.
33. PETO, R., PIKE, M.C., ARMITAGE, P., BRESLOW, N.E., COX, D.R., HOWARD, S.V., MANTEL, N., McPHERSON, K., PETO, J., and SMITH, P.O. (1977). Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II Analysis and examples. Br. J. Cancer 35, 1-39.
34. COUTELIER, J.P., VAN-BROECK, J., and WOLF, S.F. (1995). Interleukin-12 gene expression after viral infection in the mouse. J. Virol. 69, 1955-1958.
35. RUZEK, M.C., MILLER, A.H., OPAL, S.M., PEARCE, B.D., and BIRON, C.A. (1997). Characterization of early cytokine responses and an interleukin (IL)-6-dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection. J. Exp. Med. 185, 1185-1192.
36. KANANGAT, S., THOMAS, J., GANGAPPA, S., BABU, J.S., and ROUSE, B.T. (1996). Herpes simplex virus type 1-mediated up-regulation of IL-12 (p40) mRNA expression. J. Immunol. 156, 1110-1116.
37. YERKOVICH, S.T., OLVER, S.D., LENZO, J.C., PEACOCK, C.D., and PRICE, P. (1997). The roles of tumour necrosis factoralpha, interleukin-1 and interleukin-12 in murine cytomegalovirus infection. Immunology 91, 45-52.
38. TANAKA, K., KOGA, Y., LU, Y.Y., ZHANG, X.Y., WANG, Y., KIMURA, G., and NOMOTO, K. (1994). Murine cytomegalovirusassociated pneumonitis in the lungs free of the virus. J. Clin. Invest. 94, 1019-1025.
39. ORANGE, J.S., WANG, B., TERHORST, C., and BIRON, C.A. (1995). Requirement for natural killer cell-produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182, 1045-1056.
40. ORANGE, J.S., and BIRON, C.A. (1996). An absolute and restricted requirement for IL-12 in natural killer cell IFN-γ production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J. Immunol. 156, 1138-1142.
41. ORANGE, J.S., SALAZAR-MATHER, T.P., OPAL, S.M., SPENCER, R.L., MILLER, A.H., McEWEN, B.S., and BIRON, C.A. (1995). Role of TNF in IL-12-induced toxicities during viral infection. Keystone Symposium on Molecular Aspects of Viral Immunity, Keystone, CO, January 16-23, 1995. J. Cell Biochem. 19A, (Suppl.) 286.
42. LATHBURY, L.J., ALLAN, J.E., SHELLAM, G.R., and SCALZO, A.A. (1996). Effect of host genotype in determining the relative roles of natural killer cells and T cells in mediating protection against murine cytomegalovirus infection. J. Gen. Virol. 77, 2605-2613.
43. REDDEHASE, M.J., MUTTER, W., MUNCH, K., BUHRING, H.J., and KOWSINOWSKI, U.H. (1987). CD8-positive lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. J. Virol. 61, 3102-3108.